|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/10 | |
| A61K 31/5377 | |||
| A61K 31/7068 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3062809 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14802211.4 |
| Europos patento paraiškos padavimo data | 2014-10-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-09-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2014/050939 |
| Data | 2014-10-30 |
| (87) | Numeris | WO 2015/063768 |
| Data | 2015-05-07 |
| (30) | Numeris | Data | Šalis |
| 201361897921 P | 2013-10-31 | US | |
| 201461945302 P | 2014-02-27 | US |
| (72) |
PELED, Amnon, IL
ABRAHAM, Michal, IL
|
| (73) |
Biokine Therapeutics Ltd.,
Building 13a Einstein Street, Science Park Kiryat Weizmann, 7403617 Nes Ziona,
IL
BioLineRx Ltd., 2 HaMaayan Street, 7177871 Modiin, IL |
| (54) | A CXCR4 PEPTIDE INHIBITOR FOR USE IN TREATING ACUTE MYELOID LEUKEMIA WITH A FLT3 MUTATION |
| A CXCR4 PEPTIDE INHIBITOR FOR USE IN TREATING ACUTE MYELOID LEUKEMIA WITH A FLT3 MUTATION |